Cancer-fighting biotech scores $120M in Bay Area's fourth IPO of 2020
April 24, 2020 at 09:36 AM EDT
The offering from the South San Francisco cancer-focused biotech is the fourth of the year from the Bay Area and second this week.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|